Clinical Trial Update: Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary Sarcoidosis [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating hydroxychloroquine with low-dose corticosteroid for pulmonary sarcoidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• low-dose corticosteroid (corticosteroid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pulmonary Sarcoidosis | Phase 3 | Status: UNKNOWN